At Marco Island, Next-Gen Sequencers Reach Milestone as Outside Researchers Show Data | GenomeWeb
Next-generation sequencing reached a milestone last week when for the first time, independent researchers presented data that was generated on the platforms of all three front-runners for a variety of applications.
Presentations at the Advances in Genome Biology & Technology Conference, held at Marco Island, Fla., last week, showed sequencing data generated by instruments made by 454 Life Sciences, Illumina (formerly Solexa), and Applied Biosystems for applications ranging from whole-genome sequencing to genotyping and transcriptome analysis

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.